Paper36936870
Serum titer of neutralizing antibodies after COVID-19 vaccination in Japanese patients with inflammatory bowel disease.
Sugaya T and 8 others. J Clin Biochem Nutr, 2023. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Serum titer of neutralizing antibodies after COVID-19 vaccination in Japanese patients with inflammatory bowel disease. Papers, record 36936870. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36936870
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Serum titer of neutralizing antibodies after COVID-19 vaccination in Japanese patients with inflammatory bowel disease.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33082265 | Effect of IBD medications on COVID-19 outcomes: results from an international registry. | Gut | 2021 | https://conductscience.org/library/papers/33082265 | PubMed |
| 2 | 8196726 | Cyclosporine in severe ulcerative colitis refractory to steroid therapy. | N Engl J Med | 1994 | https://conductscience.org/library/papers/8196726 | PubMed |
| 3 | 22673636 | Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants. | J Crohns Colitis | 2013 | https://conductscience.org/library/papers/22673636 | PubMed |
| 4 | 35023191 | Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines. | J Med Virol | 2022 | https://conductscience.org/library/papers/35023191 | PubMed |
| 5 | 6102236 | A simple index of Crohn's-disease activity. | Lancet | 1980 | https://conductscience.org/library/papers/6102236 | PubMed |
| 6 | 33753421 | Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. | Gut | 2021 | https://conductscience.org/library/papers/33753421 | PubMed |
| 7 | 19755964 | Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. | Am J Gastroenterol | 2010 | https://conductscience.org/library/papers/19755964 | PubMed |
| 8 | 29655835 | Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases. | Gastroenterology | 2018 | https://conductscience.org/library/papers/29655835 | PubMed |
| 9 | 21674732 | Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. | Inflamm Bowel Dis | 2012 | https://conductscience.org/library/papers/21674732 | PubMed |
| 10 | 33378609 | Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33378609 | PubMed |
| 11 | 34849919 | Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study. | Inflamm Bowel Dis | 2022 | https://conductscience.org/library/papers/34849919 | PubMed |
| 12 | 29050646 | Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. | Lancet | 2017 | https://conductscience.org/library/papers/29050646 | PubMed |
| 13 | 32101660 | Escaping Pandora's Box - Another Novel Coronavirus. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32101660 | PubMed |
| 14 | 34474172 | Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis. | Autoimmun Rev | 2022 | https://conductscience.org/library/papers/34474172 | PubMed |
| 15 | 34372570 | Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2. | Viruses | 2021 | https://conductscience.org/library/papers/34372570 | PubMed |
| 16 | 33306989 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. | Lancet | 2021 | https://conductscience.org/library/papers/33306989 | PubMed |
| 17 | 34025027 | Exacerbation of liver dysfunction in non-alcoholic steatohepatitis patients during the coronavirus disease 2019 (COVID-19) pandemic. | J Clin Biochem Nutr | 2021 | https://conductscience.org/library/papers/34025027 | PubMed |
| 18 | 32527802 | The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. | Sci Immunol | 2020 | https://conductscience.org/library/papers/32527802 | PubMed |
| 19 | 27914657 | Ulcerative colitis. | Lancet | 2017 | https://conductscience.org/library/papers/27914657 | PubMed |
| 20 | 32376634 | Cell entry mechanisms of SARS-CoV-2. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/32376634 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE2 | 59272 | PubTator's text mining | https://conductscience.org/library/genes/59272 | NCBI Gene |
| IL17A | 3605 | PubTator's text mining | https://conductscience.org/library/genes/3605 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
| VTN | 7448 | PubTator's text mining | https://conductscience.org/library/genes/7448 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36936870
GET https://conductscience.org/api/papers/v1/36936870/references?page=2